Wall Street brokerages forecast that Davita Inc (NYSE:DVA) will announce earnings per share (EPS) of $1.03 for the current quarter, Zacks reports. Six analysts have made estimates for Davita’s earnings. The lowest EPS estimate is $0.96 and the highest is $1.11. Davita reported earnings of $1.05 per share during the same quarter last year, which would indicate a negative year over year growth rate of 1.9%. The firm is expected to announce its next earnings results on Wednesday, August 7th.

According to Zacks, analysts expect that Davita will report full-year earnings of $4.23 per share for the current year, with EPS estimates ranging from $4.17 to $4.34. For the next fiscal year, analysts anticipate that the company will post earnings of $5.21 per share, with EPS estimates ranging from $4.73 to $5.52. Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that follow Davita.

Davita (NYSE:DVA) last released its earnings results on Tuesday, May 7th. The company reported $0.91 earnings per share for the quarter, missing analysts’ consensus estimates of $0.95 by ($0.04). The business had revenue of $2.74 billion during the quarter, compared to the consensus estimate of $2.82 billion. Davita had a net margin of 1.15% and a return on equity of 13.96%. The firm’s revenue for the quarter was down 3.7% on a year-over-year basis. During the same period last year, the business posted $1.05 EPS.

A number of research firms recently weighed in on DVA. Zacks Investment Research downgraded shares of Davita from a “hold” rating to a “sell” rating in a research report on Thursday, April 25th. Deutsche Bank decreased their target price on shares of Davita from $68.00 to $66.00 and set a “buy” rating for the company in a research report on Thursday, May 9th. SunTrust Banks reaffirmed a “hold” rating on shares of Davita in a research report on Wednesday, February 20th. Finally, Robert W. Baird decreased their target price on shares of Davita from $90.00 to $70.00 and set an “outperform” rating for the company in a research report on Friday, February 15th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and four have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $67.78.

Several institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. grew its position in shares of Davita by 34.0% in the 4th quarter. BlackRock Inc. now owns 12,931,031 shares of the company’s stock valued at $665,428,000 after acquiring an additional 3,280,413 shares during the period. Norges Bank bought a new position in shares of Davita in the 4th quarter valued at about $274,676,000. Viking Global Investors LP grew its position in shares of Davita by 5.5% in the 1st quarter. Viking Global Investors LP now owns 2,755,505 shares of the company’s stock valued at $149,596,000 after acquiring an additional 144,876 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Davita by 2.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,645,777 shares of the company’s stock valued at $143,626,000 after acquiring an additional 66,556 shares during the period. Finally, Gates Capital Management Inc. grew its position in shares of Davita by 19.5% in the 4th quarter. Gates Capital Management Inc. now owns 2,226,221 shares of the company’s stock valued at $114,561,000 after acquiring an additional 362,588 shares during the period. 90.78% of the stock is owned by institutional investors.

Davita stock traded down $0.77 during mid-day trading on Thursday, reaching $49.23. The company’s stock had a trading volume of 1,862,325 shares, compared to its average volume of 1,542,558. The company has a market cap of $8.19 billion, a P/E ratio of 13.79, a price-to-earnings-growth ratio of 0.53 and a beta of 1.28. Davita has a 12 month low of $48.25 and a 12 month high of $79.11. The company has a current ratio of 1.12, a quick ratio of 1.11 and a debt-to-equity ratio of 2.06.

About Davita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Featured Article: How to Use the New Google Finance Tool

Get a free copy of the Zacks research report on Davita (DVA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.